| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8445840 | European Journal of Cancer | 2012 | 8 Pages |
Abstract
INDAR in concurrent chemo-radiation based on normal tissue constraints is feasible, even in patients with large tumour volumes and multi-level N2-3 disease, with acceptable severe late toxicity and promising 2-year survival.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Angela van Baardwijk, Bart Reymen, Stofferinus Wanders, Jacques Borger, Michel Ãllers, Anne-Marie C. Dingemans, Gerben Bootsma, Wiel Geraedts, Cordula Pitz, Ragnar Lunde, Frank Peters, Philippe Lambin, Dirk De Ruysscher,